Acme United reported second-quarter 2026 net sales of $62.7 million, up 16% from $54.0 million a year earlier, and net income of $5.1 million, a 6% increase versus the prior-year quarter. Diluted earnings per share were $1.22 for the quarter; six-month net sales were $115.0 million, up 15% year-over-year while six-month net income declined to $6.0 million. The company cited the January acquisition of My Medic as a contributor to sales growth but noted minimal near-term earnings impact due to My Medic’s seasonality.

Financial Highlights

  • Revenue (three months ended June 30, 2026): $62.7 million, up 16% from $54.0 million in Q2 2025.
  • Gross profit (three months ended June 30, 2026): $26.7 million; gross margin: 42.6% (versus 41.0% in Q2 2025).
  • Operating income (three months ended June 30, 2026): $6.83 million.
  • Net income (three months ended June 30, 2026): $5.05 million; diluted earnings per share: $1.22.
  • Six months ended June 30, 2026 — Net sales: $115.0 million; net income: $6.03 million; diluted EPS: $1.46.

Business Highlights

  • Acquisition of My Medic (assets acquired January 15, 2026) contributed to sales growth; My Medic is a direct-to-consumer, seasonal business with most profitability historically in Q4.
  • U.S. segment: net sales increased 17% in Q2 2026 versus Q2 2025, with first aid (excluding My Medic) up 10% in the quarter and Westcott cutting tools up 8%.
  • Europe: Q2 2026 sales increased 24% in U.S. dollars (19% in local currency), driven primarily by higher ecommerce and contribution from a cutting and sharpening product line acquired in Germany on October 1, 2025.
  • Canada: Q2 2026 sales rose modestly, driven by higher first aid product sales.
  • Operational actions post-My Medic acquisition include presenting My Medic products to industrial and retail customers, leveraging sourcing scale to reduce product costs, and reducing overhead to improve quarterly profitability over time.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.